Advanced

Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: a perspective from the EBMT cell-processing committee.

Chabannon, C; Hildebrandt, M; Scheding, Stefan LU ; Humpe, A; Lowdell, M and Slaper-Cortenbach, I (2015) In Bone Marrow Transplantation 50(3). p.321-323
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Bone Marrow Transplantation
volume
50
issue
3
pages
321 - 323
publisher
Nature Publishing Group
external identifiers
  • pmid:25501349
  • wos:000351632000001
  • scopus:84938414967
ISSN
1476-5365
DOI
10.1038/bmt.2014.271
language
English
LU publication?
yes
id
e845dc7e-c48f-48e6-8c9d-28a1c0444b93 (old id 4908413)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25501349?dopt=Abstract
date added to LUP
2015-01-11 19:40:05
date last changed
2017-08-27 03:10:42
@misc{e845dc7e-c48f-48e6-8c9d-28a1c0444b93,
  author       = {Chabannon, C and Hildebrandt, M and Scheding, Stefan and Humpe, A and Lowdell, M and Slaper-Cortenbach, I},
  issn         = {1476-5365},
  language     = {eng},
  number       = {3},
  pages        = {321--323},
  publisher    = {Nature Publishing Group},
  series       = {Bone Marrow Transplantation},
  title        = {Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: a perspective from the EBMT cell-processing committee.},
  url          = {http://dx.doi.org/10.1038/bmt.2014.271},
  volume       = {50},
  year         = {2015},
}